Analyst Ratings for Rexnord Corp. (RXN)Updated: 2017-07-27
Rexnord Corp. (NYSE:RXN) was awarded an average rating of Overweight from investment analysts following the stock. About 30 days ago, RXN was issued an average rating of Overweight.
Of the 9 analysts covering the stock, 5 gave it a buy rating, 1 issued an overweight rating, 1 issued a hold rating, 1 issued an underweight rating, and 1 issued a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.
Several price targets were given for RXN by the analysts covering the stock. The most optimistic price target was 27, which equates to a potential upside of 15.88 percent. The minimum price target given was 18, implying potential capital losses of -22.75 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.
In the last 30 days, analysts have changed their quarterly earnings estimates downwards by an average of -3.7 percent. The average change in earnings estimates over the last 90 days is -7.14 percent. Meanwhile, fiscal year estimates have been revised downwards by -1.17 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -4.89 percent.
Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 1 analysts made negative revisions. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, compared to 1 analysts that revised their FY estimates downwards.
The growth rate of RXN's earnings is estimated by analysts to be 88.49 percent. People on Wall Street often look at a company's PEG ratio. Investors like to see smaller values for the PEG ratio, because people typically see that as an indicator of higher growth relative to stock price. PEG ratios below 1 are often considered desirable, but many choose to perform ratio comparisons with other companies in the industry. The PEG ratio of RXN is 0.41.
RXN has a 52-week high of 25.00 and a 52-week low of 15.80. Today's price is 47.47 percent above the 52-week low, and 6.8 percent lower than its 52-week high. RXN has a price/earnings ratio of 35.85. Investors typically compare the P/E ratio to a company's peers in the industry. The RXN value stock report compares RXN to some of its peers using value stock charts. The market cap of RXN is $2.48 billion. RXN is estimated to release their earnings results for the quarter on 0000-00-00, days from today.